- Home
- TD vs PFE Comparison
TD vs PFE Comparison
Compare TD & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TD | PFE |
|---|---|---|
| Founded | 1855 | 1849 |
| Country | Canada | United States |
| Employees | 102218 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.3B | 155.2B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | TD | PFE |
|---|---|---|
| Price | $94.32 | $27.29 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 13 |
| Target Price | ★ $120.00 | $28.15 |
| AVG Volume (30 Days) | 1.5M | ★ 31.2M |
| Earning Date | 02-26-2026 | 04-28-2026 |
| Dividend Yield | 3.22% | ★ 6.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.36 |
| Revenue | N/A | ★ $62,579,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.22 | N/A |
| P/E Ratio | ★ $11.65 | $20.19 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $54.87 | $20.92 |
| 52 Week High | $99.84 | $27.94 |
Technical Indicators
Market Signals| Indicator | TD | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 54.50 |
| Support Level | $93.09 | $23.83 |
| Resistance Level | $96.41 | $27.67 |
| Average True Range (ATR) | 1.77 | 0.57 |
| MACD | -0.33 | -0.01 |
| Stochastic Oscillator | 17.16 | 67.63 |
Price Performance
Historical ComparisonAbout TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.